AAAAAA

   
Results: 1-11 |
Results: 11
SYMPTOMS ARE A POOR INDICATION OF SEVERITY OF REFLUX IN BARRETTS-ESOPHAGUS
Authors: MULLIGAN ED PURCELL T LAWLOR P REYNOLDS JV BYRNE PJ HENNESSY TPJ
Citation: Ed. Mulligan et al., SYMPTOMS ARE A POOR INDICATION OF SEVERITY OF REFLUX IN BARRETTS-ESOPHAGUS, Gastroenterology, 114(4), 1998, pp. 967-967
ADENOCARCINOMA OF ESOPHAGUS JUNCTION AND CARDIA - SIMILAR RESPONSE TONEOADJUVANT THERAPY
Authors: MULLIGAN ED DUNNE B PURCELL T GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., ADENOCARCINOMA OF ESOPHAGUS JUNCTION AND CARDIA - SIMILAR RESPONSE TONEOADJUVANT THERAPY, Gastroenterology, 114(4), 1998, pp. 2673-2673
ADJUNCTIVE CHEMORADIOTHERAPY IN ESOPHAGEAL-CARCINOMA DOES NOT INCREASE POSTOPERATIVE MORBIDITY OR MORTALITY
Authors: MULLIGAN ED DUNNE B PURCELL T GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., ADJUNCTIVE CHEMORADIOTHERAPY IN ESOPHAGEAL-CARCINOMA DOES NOT INCREASE POSTOPERATIVE MORBIDITY OR MORTALITY, Gastroenterology, 114(4), 1998, pp. 2674-2674
CLINICOPATHOLOGICAL FACTORS IN THE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA
Authors: MULLIGAN ED DUNNE B PURCELL T GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., CLINICOPATHOLOGICAL FACTORS IN THE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA, Gastroenterology, 114(4), 1998, pp. 2675-2675
THE IMPORTANCE OF NEGATIVE MICROSCOPY MARGINS IN THE MULTIMODALITY THERAPY OF ESOPHAGEAL CANCER
Authors: MULLIGAN ED DUNNE B PURCELL T GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., THE IMPORTANCE OF NEGATIVE MICROSCOPY MARGINS IN THE MULTIMODALITY THERAPY OF ESOPHAGEAL CANCER, Gastroenterology, 114(4), 1998, pp. 2676-2676
IMPORTANCE OF NEGATIVE MICROSCOPIC MARGINS IN THE MULTIMODALITY THERAPY OF ESOPHAGEAL CANCER
Authors: MULLIGAN ED WALSH TN DUNNE B PURCELL T GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., IMPORTANCE OF NEGATIVE MICROSCOPIC MARGINS IN THE MULTIMODALITY THERAPY OF ESOPHAGEAL CANCER, British Journal of Surgery, 85(5), 1998, pp. 695-695
TUMOR LENGTH PREDICTS RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA
Authors: MULLIGAN ED WALSH TN DUNNE B PURCELL T GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., TUMOR LENGTH PREDICTS RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA, British Journal of Surgery, 85(5), 1998, pp. 696-696
ADJUNCTIVE CHEMORADIOTHERAPY IN ESOPHAGEAL-CARCINOMA - NO INCREASE INPOSTOPERATIVE MORBIDITY OR MORTALITY
Authors: MULLIGAN ED PURCELL T DUNNE B GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., ADJUNCTIVE CHEMORADIOTHERAPY IN ESOPHAGEAL-CARCINOMA - NO INCREASE INPOSTOPERATIVE MORBIDITY OR MORTALITY, British Journal of Surgery, 85, 1998, pp. 29-29
ADENOCARCINOMA OF ESOPHAGUS JUNCTION AND CARDIA - SIMILAR RESPONSE TONEOADJUVANT THERAPY
Authors: MULLIGAN ED PURCELL T DUNNE B GRIFFIN M NOONAN N HOLLYWOOD D KEELING N REYNOLDS JV HENNESSY TPJ
Citation: Ed. Mulligan et al., ADENOCARCINOMA OF ESOPHAGUS JUNCTION AND CARDIA - SIMILAR RESPONSE TONEOADJUVANT THERAPY, British Journal of Surgery, 85, 1998, pp. 86-86
THE ROLE OF SURGERY AND LASER-ABLATION IN ESOPHAGEAL-CARCINOMA
Authors: MULLIGAN ED ORIORDAIN MG DUGGAN M CROWE J LENNON J MACMATHUNA P FITZPATRICK JM GOREY TF
Citation: Ed. Mulligan et al., THE ROLE OF SURGERY AND LASER-ABLATION IN ESOPHAGEAL-CARCINOMA, Irish journal of medical science, 166(4), 1997, pp. 203-205
HIGH-INTENSITY FOCUSED ULTRASOUND IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
Authors: MULLIGAN ED LYNCH TH MULVIN D GREENE D SMITH JM FITZPATRICK JM
Citation: Ed. Mulligan et al., HIGH-INTENSITY FOCUSED ULTRASOUND IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA, British Journal of Urology, 79(2), 1997, pp. 177-180
Risultati: 1-11 |